BioMarin Pharmaceutical Inc.BMRNNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-402.36%
↓ 6009% below average
Average (39q)
-6.59%
Historical baseline
Range
High:26.78%
Low:-402.36%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -402.36% |
| Q3 2025 | -5.97% |
| Q2 2025 | 10.77% |
| Q1 2025 | -0.29% |
| Q4 2024 | 0.21% |
| Q3 2024 | 4.73% |
| Q2 2024 | 9.74% |
| Q1 2024 | 0.41% |
| Q4 2023 | 11.16% |
| Q3 2023 | -2.34% |
| Q2 2023 | -0.19% |
| Q1 2023 | 10.95% |
| Q4 2022 | 6.37% |
| Q3 2022 | -5.33% |
| Q2 2022 | 2.78% |
| Q1 2022 | 15.46% |
| Q4 2021 | 10.05% |
| Q3 2021 | -18.53% |
| Q2 2021 | 3.22% |
| Q1 2021 | 7.50% |
| Q4 2020 | -5.17% |
| Q3 2020 | 11.01% |
| Q2 2020 | -14.45% |
| Q1 2020 | 10.47% |
| Q4 2019 | -1.44% |
| Q3 2019 | 18.91% |
| Q2 2019 | -3.24% |
| Q1 2019 | 13.46% |
| Q4 2018 | -9.83% |
| Q3 2018 | 5.06% |
| Q2 2018 | -0.16% |
| Q1 2018 | 4.23% |
| Q4 2017 | 7.23% |
| Q3 2017 | 5.26% |
| Q2 2017 | 4.51% |
| Q1 2017 | 1.22% |
| Q4 2016 | 7.22% |
| Q3 2016 | -6.74% |
| Q2 2016 | 26.78% |
| Q1 2016 | 3.86% |